Randomised Evaluation of COVID-19 Therapy
Conditions
Pneumonia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Belgian sites are managed by the European Clinical Research Alliance on Infectious Diseases, Brussels, Belgium
Estonian sites are managed by the European Clinical Research Alliance on Infectious Diseases, Tallinn, Estonia
French sites are managed by the European Clinical Research Alliance on Infectious Diseases, Paris, France
Kumasi Center for Collaborative Research in Tropical Medicine KNUST, Kumasi, Ghana
Indian Council of Medical Research, Division of Epidemiology and Communicable Diseases, New Delhi, India
Eijkman Oxford Clinical Research Unit (EOCRU), Eijkman Institute for Molecular Biology, Jakarta, Indonesia
Italian sites are managed by the European Clinical Research Alliance on Infectious Diseases, Roma, Italy
Clinical Trial Unit, Oxford University Clinical Research Unit-Nepal, Patan Academy of Health Sciences, Kathmandu, Nepal
Dutch sites are managed by the European Clinical Research Alliance on Infectious Diseases, Utrecht, Netherlands
Portuguese sites are managed by the European Clinical Research Alliance on Infectious Diseases, Lisbon, Portugal
Romanian sites are managed by the European Clinical Research Alliance on Infectious Diseases, Bucharest, Romania
Wits Health Consortium, Johannesburg, South Africa
Spanish sites are managed by the European Clinical Research Alliance on Infectious Diseases, Barcelona, Spain
Swedish sites are managed by the European Clinical Research Alliance on Infectious Diseases, Stockholm, Sweden
Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom
Contact: Principal Investigator (Peter W Horby)Oxford University Clinical Research Unit, Centre for Tropical Medicine, Ho Chi Minh City, Vietnam
Study leads
Peter W Horby
Principal Investigator
University of Oxford